Dr. Lal PathLabs Limited
LALPATHLAB
Rank in Stocks
#4516
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Share Price
$20.35
Last synced: 2026-10-19
Market Cap
$3.40B
Change (1 day)
-0.86%
Change (1 year)
13.63%
Country
IN
Trade Dr. Lal PathLabs Limited (LALPATHLAB)
Category
Healthcare
Number of shares outstanding for Dr. Lal PathLabs Limited (LALPATHLAB)
Number of shares outstanding as of June 2026: 167.00M
According to Dr. Lal PathLabs Limited latest financial reports and stock price the company's current number of shares outstanding is 167.00M. At the end of March 2024 the company had 166.47M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Dr. Lal PathLabs Limited (LALPATHLAB) from 2011 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 167.00M | 0.10% |
| 2025 | 166.83M | 0.22% |
| 2024 | 166.47M | 0.15% |
| 2023 | 166.21M | 0.19% |
| 2022 | 165.90M | 0.27% |
| 2021 | 165.46M | 0.22% |
| 2020 | 165.10M | 0.09% |
| 2019 | 164.95M | 0.58% |
| 2018 | 164.01M | 0.52% |
| 2017 | 163.15M | -1.38% |
| 2016 | 165.44M | 0.73% |
| 2015 | 164.24M | 0.00% |
| 2014 | 164.24M | 6.99% |
| 2013 | 153.51M | -7.13% |
| 2012 | 165.29M | 0.00% |
| 2011 | 165.29M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 371.00M | 122.16% |
US
|
|
| 705.30M | 322.35% |
US
|
|
| 143.28M | -14.20% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.87% |
US
|
